文献速递心脏核医学

CT衰减校正改善肥胖患者心脏SPECT的定量风险预测

CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-11-04

本研究纳入4585例接受碲锌镉(CZT)SPECT/CT心肌灌注显像的患者,比较CT衰减校正的负荷总灌注缺损(AC-sTPD)与非校正负荷总灌注缺损(NC-sTPD)对主要不良心脏事件(MACE)的预测价值。中位随访25个月期间453例(10%)发生MACE;在BMI≥35 kg/m2患者中,AC-sTPD≥3%者无MACE生存率更差(HR 2.23),而NC-sTPD≥3%与<3%者无差异,AC-sTPD的AUC高于NC-sTPD。结论认为AC-sTPD在BMI≥35 kg/m2患者中预测MACE优于NC-sTPD。

要点

  • BMI≥35 kg/m2患者中,AC-sTPD≥3%者MACE风险更高(HR 2.23,95%CI 1.40-3.55)。
  • 同组NC-sTPD≥3%与<3%者无MACE生存无显著差异(HR 1.06,95%CI 0.67-1.68)。
  • BMI≥35 kg/m2患者2年MACE检测AUC:AC-sTPD 0.631 vs NC-sTPD 0.541(p=0.01)。

核心结论

  • 在BMI≥35 kg/m2接受SPECT MPI的患者中,AC-sTPD预测MACE优于NC-sTPD。
  • 这些发现突显了AC-sTPD在该患者人群中的优越预后价值,并强调了CT衰减校正的重要性。

研究设计与样本

  • 研究纳入4585例因临床指征(胸痛56%、气短13%、其他32%)在耶鲁纽黑文医院接受CZT SPECT/CT MPI的患者(年龄64±12岁,45%女性,BMI 30.0±6.3 kg/m2,既往冠心病18%)。
  • 采用生存分析评估AC-sTPD或NC-sTPD与MACE(死亡、非致死性心肌梗死或SPECT后>90天晚期冠状动脉血运重建的复合终点)的关联。

主要发现

  • 中位随访25个月期间,453例(10%)发生MACE。
  • BMI≥35 kg/m2患者(n=931)中,AC-sTPD≥3%者无MACE生存差于AC-sTPD<3%者(HR 2.23,95%CI 1.40-3.55,p=0.002)。
  • BMI≥35 kg/m2患者中,NC-sTPD≥3%与NC-sTPD<3%者无MACE生存无差异(HR 1.06,95%CI 0.67-1.68,p=0.78)。
  • BMI≥35 kg/m2患者中,AC-sTPD检测2年MACE的AUC高于NC-sTPD(0.631 vs 0.541,p=0.01)。
  • 总体队列中,AC-sTPD检测2年MACE的ROC曲线下面积(AUC 0.641)高于NC-sTPD(0.608;P=0.01)。

关键数值与推荐

  • AC-sTPD阈值3%用于BMI≥35 kg/m2患者的风险分层(HR 2.23,95%CI 1.40-3.55,p=0.002)。
  • NC-sTPD阈值3%在BMI≥35 kg/m2患者中未显示与MACE的显著关联(HR 1.06,95%CI 0.67-1.68,p=0.78)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to compare the predictive value of CT attenuation-corrected stress total perfusion deficit (AC-sTPD) and non-corrected stress TPD (NC-sTPD) for major adverse cardiac events (MACE) in obese patients undergoing cadmium zinc telluride (CZT) SPECT myocardial perfusion imaging (MPI). METHODS: The study included 4,585 patients who underwent CZT SPECT/CT MPI for clinical indications (chest pain: 56%, shortness of breath: 13%, other: 32%) at Yale New Haven Hospital (age: 64 ± 12 years, 45% female, body mass index [BMI]: 30.0 ± 6.3 kg/m2, prior coronary artery disease: 18%). The association between AC-sTPD or NC-sTPD and MACE defined as the composite end point of mortality, nonfatal myocardial infarction or late coronary revascularization (> 90 days after SPECT) was evaluated with survival analysis. RESULTS: During a median follow-up of 25 months, 453 patients (10%) experienced MACE. In patients with BMI ≥ 35 kg/m2 (n = 931), those with AC-sTPD ≥ 3% had worse MACE-free survival than those with AC-sTPD < 3% (HR: 2.23, 95% CI: 1.40 - 3.55, p = 0.002) with no difference in MACE-free survival between patients with NC-sTPD ≥ 3% and NC-sTPD < 3% (HR:1.06, 95% CI:0.67 - 1.68, p = 0.78). AC-sTPD had higher AUC than NC-sTPD for the detection of 2-year MACE in patients with BMI ≥ 35 kg/m2 (0.631 versus 0.541, p = 0.01). In the overall cohort AC-sTPD had a higher ROC area under the curve (AUC, 0.641) than NC-sTPD (0.608; P = 0.01) for detection of 2-year MACE. In patients with BMI ≥ 35 kg/m2 AC sTPD provided significant incremental prognostic value beyond NC sTPD (net reclassification index: 0.14 [95% CI: 0.20 - 0.28]). CONCLUSIONS: AC sTPD outperformed NC sTPD in predicting MACE in patients undergoing SPECT MPI with BMI ≥ 35 kg/m2. These findings highlight the superior prognostic value of AC-sTPD in this patient population and underscore the importance of CT attenuation correction.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Feher A, Pieszko K, Shanbhag A, et al. CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients. Eur J Nucl Med Mol Imaging. 2023. PMID: 37924340. doi:10.1007/s00259-023-06484-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。